Safety and efficacy of 3 dose levels Extrafine glycopyrronium bromide (GB) when added to fixed dose combination of extrafine BDP/FF in uncontrolled asthma patients
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Glycopyrrolate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 01 Nov 2018 New trial record
- 19 Sep 2018 Primary endpoint (FEV1 AUC0-12h) has been met.
- 19 Sep 2018 Results assessing the efficacy and safety of glycopyrronium bromide 3 doses in combination with beclomethasone dipropionate/formoterol fumarate in asthmatic patients, presented at the 28th Annual Congress of the European Respiratory Society.